Prognostic Value of Novel CARWL Score in Stage IIIC Non-Small-Cell Lung Cancer Patients Undergoing Concurrent Chemoradiotherapy.

Erkan Topkan Ahmet Kucuk Duriye Ozturk Emine Elif OzkanAli Ayberk BesenBerrin Pehlivan Ugur Selek

Published in: Canadian respiratory journal (2024)

Our findings indicate that the novel CARWL score, which accounts for pretreatment CAR and significant WL during the preceding 6 months, can reliably stratify newly diagnosed stage IIIC NSCLC patients into three groups with significantly different PFS and OS after definitive CCRT.

Keyphrases

newly diagnosed
patients undergoing
locally advanced
end stage renal disease
small cell lung cancer
ejection fraction
chronic kidney disease
prognostic factors
advanced non small cell lung cancer